Ray-Coquard, I., Favier, L., Weber, B., Roemer-Becuwe, C., Bougnoux, P., Fabbro, M., . . . Pujade-Lauraine, E. (2013). Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO. Nature Publishing Group.
Chicago Style CitationRay-Coquard, I., et al. Everolimus As Second- or Third-line Treatment of Advanced Endometrial Cancer: ENDORAD, a Phase II Trial of GINECO. Nature Publishing Group, 2013.
Cita MLARay-Coquard, I., et al. Everolimus As Second- or Third-line Treatment of Advanced Endometrial Cancer: ENDORAD, a Phase II Trial of GINECO. Nature Publishing Group, 2013.
Atenció: Aquestes cites poden no estar 100% correctes.